vascular dementia: A degenerative vascular disorder affecting the brain. It is caused by the blockage of the blood supply to the brain. It is manifested with decline of memory and cognitive functions.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
545 |
4. Check minimum number of eventsNone |
545 |
5. Include endpointsNone |
545 |
6. Filter based on genotype QC (FinnGen only) |
545 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F01
- Name in latin
- Dementia vascularis corticalis et subcorticalis mixta
Similar endpoints
↥List of similar endpoints to
Vascular dementia (mixed)
based on the number of shared cases.
Similar with more cases:
- Vascular dementia
- Any dementia
- Any dementia, excluding more controls
- Dementia
- Dementia, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6720 | 3614 | 3030 |
| Only index persons | 5076 | 2802 | 2274 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.10 | 0.08 |
| Only index persons | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 82.65 | 84.38 | 80.68 |
| Only index persons | 83.34 | 85.10 | 81.18 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 545 | 200 | 345 |
| Unadjusted period prevalence (%) | 0.12 | 0.07 | 0.15 |
| Median age at first event (years) | 81.34 | 82.38 | 80.74 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 447
- Matched controls
- 4468
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
3710.2
223.5
197
*
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
+∞
159.1
143
*
N06DX01
ATC
memantine; oral
159.7
115.6
118
10
F01.39
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without information on additional symptoms
+∞
106.6
98
*
F03
ICD-10 Finland
Unspecified dementia
49.8
86.5
104
27
N06DA02
ATC
donepezil; oral
109.6
75.9
81
9
G30.1
ICD-10 Finland
Alzheimer disease with late onset
58.8
63.5
74
15
F01.34
ICD-10 Finland
Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type
648.5
59.1
57
*
N05AX08
ATC
risperidone; systemic
11.0
54.1
110
129
F01.9
ICD-10 Finland
Vascular dementia, unspecified
84.5
53.5
59
8
N06DA03
ATC
rivastigmine; oral, transdermal
122.5
51.0
54
5
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
6.3
49.8
154
344
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
45.6
43
*
P20
ICPC
Memory disturbance
5.8
43.9
145
344
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
7.6
43.5
111
186
N06DA04
ATC
galantamine; oral
102.3
42.7
46
5
A28
ICPC
Limited function/disability NOS
4.1
35.5
178
627
G30.8
ICD-10 Finland
Other Alzheimer disease
195.2
35.3
36
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
130.2
34.2
36
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.9
31.1
155
532
N05AH04
ATC
quetiapine; oral
6.0
30.8
92
185
SPAT1053
SPAT
Memory test
3.6
26.9
147
535
R41.0
ICD-10 Finland
Disorientation, unspecified
9.0
26.3
57
71
AA1AD
NOMESCO Finland
CT of head and brain
3.1
24.4
178
788
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.9
23.8
208
1034
R53
ICD-10 Finland
Malaise and fatigue
3.3
23.7
148
585
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
23.5
159
664
F01.33
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly depression
+∞
23.1
22
*
L28
ICPC
Limited function/disability (L)
3.2
21.6
133
516
F05.1
ICD-10 Finland
Delirium superimposed on dementia
60.4
20.1
23
*
N06AB04
ATC
citalopram; systemic
3.2
19.9
124
482
N03AG01
ATC
valproic acid; systemic, rectal
9.3
19.6
41
48
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
26.4
18.4
25
10
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
+∞
17.8
17
*
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.6
17.6
85
270
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.6
17.3
86
280
N06AX11
ATC
mirtazapine; oral
2.6
16.8
147
698
F01.32
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations
+∞
16.8
16
*
F01.31
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly paranoidism
176.3
16.6
17
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4.2
16.4
66
178
SPAT1216
SPAT
Assessment of functional ability
2.9
15.8
112
466
F05.9
ICD-10 Finland
Delirium, unspecified
7.8
15.3
35
48
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
24.4
15.2
21
9
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
154.8
14.5
15
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.7
14.0
106
457
K90
ICPC
Stroke/cerebrovascular accident
5.4
12.8
38
75
N05BA04
ATC
oxazepam; oral
2.4
12.7
131
662
N30.0
ICD-10 Finland
Acute cystitis
2.7
11.9
88
371
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
66.7
11.7
13
*
N05AD01
ATC
haloperidol; systemic
5.4
11.5
34
67
P70
ICPC
Dementia
12.3
11.4
20
17
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
11.0
11.4
21
20
N05AH03
ATC
olanzapine; systemic
7.1
11.3
27
40
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
11.3
105
501
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
10.8
98
461
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.3
10.8
28
47
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
10.7
176
1081
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.1
10.6
33
69
R41.3
ICD-10 Finland
Other amnesia
5.8
10.5
29
53
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
+∞
10.5
10
*
F05.8
ICD-10 Finland
Other delirium
12.6
9.9
17
14
N05AD03
ATC
melperone; systemic
8.1
9.7
21
27
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.6
9.6
76
331
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.4
9.6
46
145
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.9
9.4
38
104
SPAT1234
SPAT
Support of social functional capacity
3.7
9.3
40
115
SPAT1360
SPAT
Extensive global examination
3.3
9.1
46
151
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.7
9.0
38
108
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
4.1
9.0
34
88
C10AA01
ATC
simvastatin; oral
1.8
8.8
252
1848
B01AC04
ATC
clopidogrel; oral
2.0
8.7
122
692
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.6
8.6
38
112
N02BE01
ATC
paracetamol; systemic, rectal
2.0
8.6
346
2843
N06AB10
ATC
escitalopram; oral
2.8
8.5
56
219
I95.1
ICD-10 Finland
Orthostatic hypotension
3.5
8.4
39
120
F01.0
ICD-10 Finland
Vascular dementia of acute onset
+∞
8.4
8
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
8.2
305
2415
F06.7
ICD-10 Finland
Mild cognitive disorder
5.0
8.2
25
52
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
8.1
87
440
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
4.1
8.0
30
77
S72.0
ICD-10 Finland
Fracture of neck of femur
3.0
8.0
46
166
SPAT1254
SPAT
Administration of medicine
2.2
8.0
88
451
A06AD11
ATC
lactulose; oral
2.0
7.8
114
654
C07AB07
ATC
bisoprolol; oral
1.8
7.8
264
2014
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
45.8
7.7
9
*
R55
ICD-10 Finland
Syncope and collapse
2.3
7.7
74
357
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.2
7.6
39
130
K91
ICPC
Cerebrovascular disease
5.9
7.6
20
35
R4120
NOMESCO Finland
Occupational therapy
3.4
7.5
35
109
A04
ICPC
Weakness/tiredness general
2.3
7.5
72
345
WYA20
NOMESCO Finland
Home visit
6.6
7.5
18
28
G30
ICD-10 Finland
Alzheimer disease
+∞
7.3
7
*
N03AF02
ATC
oxcarbazepine; oral
5.2
7.2
21
42
F01
ICD-10 Finland
Vascular dementia
30.5
7.2
9
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.8
7.2
46
178
W06
ICD-10 Finland
Fall involving bed
12.3
7.1
12
10
F21
ICPC
NA
9.0
7.1
14
16
R42
ICD-10 Finland
Dizziness and giddiness
1.9
7.1
117
702
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.0
7.1
97
543
J01DB01
ATC
cefalexin; oral
1.7
7.1
296
2369
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
7.0
108
633
SPAT1301
SPAT
No procedures
1.8
7.0
148
965
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
8.5
6.9
14
17
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
6.8
86
468
I63.8
ICD-10 Finland
Other cerebral infarction
8.0
6.7
14
18
N05BA06
ATC
lorazepam; systemic, sublingual
3.0
6.6
37
130
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.6
6.6
21
47
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
5.5
6.5
18
34
Y94.0
ICD-10 Finland
Accident at home
5.5
6.5
18
34
SPAT1252
SPAT
Overall medication plan or its review
2.5
6.5
48
202
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
70.8
6.4
7
*
N18
ICPC
Paralysis/weakness
4.9
6.3
19
40
F0019, G301
ICD-10 Finland
NA
+∞
6.3
6
*
130
Kela drug reimbursment
Malignant tumour
0.2
6.1
7
306
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.3
6.1
29
93
S70.0
ICD-10 Finland
Contusion of hip
3.1
6.0
31
105
Z3226
NOMESCO Finland
Physiotherapist
2.0
6.0
84
472
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
226
960
3.31
39.47
2.1
1.8
nmol/l
1064.8
1184.1
1.26
172
716
(3023368) Bacteria identified in Blood by Culture
254
1296
2.80
30.15
4.4
4.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
241
1259
2.64
26.47
2.9
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
142
565
3.05
26.26
2.5
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
176
791
2.81
25.99
2.4
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
140
567
2.98
24.97
2.4
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
186
890
2.65
23.99
6.2
4.4
ng/l
79.5
209.3
1.91
170
807
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
243
1325
2.50
23.78
2.3
2.2
nmol/l
75.3
80.6
2.18
210
1148
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
226
1197
2.52
23.49
2.6
2.0
u/l
203.4
313.4
0.90
215
1116
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
316
1967
2.44
22.76
7.0
6.3
mmol/l
1.2
1.2
1.61
266
1619
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
295
1781
2.43
22.76
6.1
5.6
mmol/l
1.2
1.2
0.04
265
1588
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
287
1715
2.42
22.62
2.8
2.2
pmol/l
88.0
91.4
0.67
172
894
(3026008) Bacteria identified in Urine by Culture
247
1417
2.36
20.90
4.3
3.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
54
141
4.14
18.88
6.0
4.8
mmol/l
1.4
1.4
0.10
45
123
(3024561) Albumin [Mass/volume] in Serum or Plasma
276
1722
2.22
18.43
5.2
4.5
g/l
33.5
33.8
0.28
248
1576
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
117
508
2.66
17.76
4.6
3.2
ng/l
299.5
330.8
0.27
112
465
(3031040) Bacteria [#/volume] in Urine by Automated count
357
2499
2.24
17.53
7.6
5.5
e6/l
5053.7
3002.7
—
6
63
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
87
325
3.00
17.52
1.6
1.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
43
104
4.40
16.59
6.2
5.0
mmol/l
104.2
105.3
0.52
38
93
(3039000) Anion gap in Blood
43
104
4.40
16.59
6.2
5.0
mmol/l
10.9
11.9
0.74
38
93
(3013826) Glucose [Moles/volume] in Serum or Plasma
326
2264
2.09
15.50
5.9
4.7
mmol/l
7.1
7.0
0.56
314
2128
(3015377) Calcium [Moles/volume] in Serum or Plasma
215
1282
2.12
15.40
2.8
3.2
mmol/l
2.3
2.3
1.16
183
1093
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
289
1945
2.03
14.68
4.5
5.5
umol/l
12.8
13.3
0.15
264
1838
(3021960) Folate [Moles/volume] in Serum or Plasma
186
1066
2.13
14.63
1.9
1.6
nmol/l
17.5
19.9
1.33
169
894
(3018418) pH of Serum or Plasma
200
1208
2.04
13.45
3.8
3.9
ph
7.4
7.4
0.11
25
239
(3023183) Ammonium ion [Moles/volume] in Plasma
32
73
4.59
13.26
1.3
2.1
umol/l
24.9
37.5
1.42
25
59
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
363
2725
1.99
12.71
7.0
7.0
u/l
82.6
83.8
0.12
338
2524
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
193
1171
2.00
12.67
2.7
2.2
mg/l
2.8
3.2
1.77
159
995
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
69
270
2.78
12.64
1.5
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
251
1683
1.91
12.15
3.5
2.8
u/l
55.2
58.3
0.20
225
1508
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
160
936
2.00
11.46
1.6
1.8
pmol/l
409.8
7692730.9
0.50
132
741
(3037467) Urinalysis macro (dipstick) panel - Urine
331
2466
1.87
11.18
6.2
4.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
369
2851
1.91
11.06
4.9
4.7
mu/l
1.9
2.1
2.05
331
2485
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
71
302
2.55
11.00
2.1
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
182
1137
1.90
10.62
4.7
5.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
71
307
2.51
10.62
6.7
5.6
mmol/l
25.3
24.3
0.90
64
285
(3019060) Gas panel - Arterial blood
76
340
2.44
10.57
4.8
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
401
3208
1.95
10.52
28.9
19.6
mg/l
29.7
29.2
0.12
375
2740
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
106
549
2.16
10.44
5.2
5.7
kpa
5.1
5.0
0.46
93
517
(3027801) Oxygen [Partial pressure] in Arterial blood
106
550
2.15
10.39
5.2
5.7
kpa
10.7
11.4
0.62
91
518
(3003396) Base excess in Arterial blood by calculation
106
551
2.15
10.34
5.2
5.8
mmol/l
2.0
1.3
0.79
83
414
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
151
3.08
10.17
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
138
800
1.97
9.98
3.1
3.3
mmol/l
2.4
2.5
1.52
119
679
(3002032) Base excess in Venous blood by calculation
91
456
2.20
9.70
2.1
3.5
mmol/l
2.0
2.0
0.01
74
349
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
57
234
2.60
9.47
7.1
7.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
85
421
2.21
9.31
5.8
6.6
g/l
117.9
118.1
0.03
79
403
(3032080) INR in Blood by Coagulation assay
257
1846
1.74
9.11
11.5
13.3
inr
1.5
1.4
0.43
51
505
(3021447) Carbon dioxide [Partial pressure] in Venous blood
90
460
2.15
9.10
2.1
3.5
kpa
5.9
5.8
0.16
85
438
(3007930) Methemoglobin/Hemoglobin.total in Blood
50
196
2.71
9.10
5.8
4.0
%
1.0
0.9
1.08
45
183
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
50
197
2.69
9.01
5.8
4.0
%
1.9
1.6
1.74
45
182
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
41
150
2.87
8.49
1.6
1.6
%
1.6
1.7
0.33
31
116
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
11
13
8.62
8.49
1.0
1.0
ng/l
669.7
532.2
—
6
5
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
30
5.46
8.25
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
30
5.46
8.25
1.3
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
315
2437
1.69
8.17
40.1
26.8
g/l
329.2
330.1
0.77
308
2402
(3009542) Hematocrit [Volume Fraction] of Blood
337
2655
1.71
8.17
35.2
21.6
%
35.8
36.6
0.47
167
1493
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
298
2286
1.67
7.87
3.5
3.7
pmol/l
15.1
15.3
0.30
263
1987
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
170
1125
1.74
7.80
2.6
2.3
u/l
63.3
57.8
0.41
159
1033
(3016502) Oxygen saturation in Arterial blood
90
487
2.02
7.78
5.6
6.1
%
95.8
95.0
0.81
82
467
(3001122) Ferritin [Mass/volume] in Serum or Plasma
204
1427
1.69
7.61
3.1
2.9
ug/l
138.1
165.2
0.90
179
1271
(3019550) Sodium [Moles/volume] in Serum or Plasma
403
3384
1.73
7.23
35.0
24.0
mmol/l
139.3
139.3
0.07
394
3282
(40761511) CBC panel - Blood by Automated count
387
3216
1.70
7.20
27.3
19.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
403
3386
1.73
7.19
35.4
24.2
mmol/l
4.0
4.0
2.24
393
3282
(3007461) Platelets [#/volume] in Blood
404
3403
1.72
7.07
40.1
28.7
e9/l
230.0
231.3
0.13
391
3292
(3000963) Hemoglobin [Mass/volume] in Blood
404
3404
1.72
7.05
40.1
28.9
g/l
125.2
129.4
6.16
395
3325
(3026361) Erythrocytes [#/volume] in Blood
404
3404
1.72
7.05
40.0
28.7
e12/l
4.2
4.3
3.94
388
3282
(3024731) MCV [Entitic volume]
404
3404
1.72
7.05
39.9
28.6
fl
92.0
92.1
0.09
394
3325
(3035941) MCH [Entitic mass]
404
3404
1.72
7.05
39.9
28.5
pg
30.4
30.4
0.35
394
3324
(3010813) Leukocytes [#/volume] in Blood
404
3405
1.72
7.04
40.0
28.7
e9/l
7.6
7.1
3.12
389
3279
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
108
648
1.83
6.81
2.3
2.6
%
20.8
20.6
0.03
64
557
(3014271) Vancomycin [Susceptibility]
15
32
4.79
6.72
2.5
3.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
206
1490
1.62
6.51
5.4
5.3
%
0.6
0.6
0.12
192
1369
(3000991) Gas panel - Venous blood
71
377
2.02
6.44
3.5
7.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
213
1564
1.59
6.27
6.4
5.7
%
22.4
24.3
1.42
198
1432
(3013707) Erythrocyte sedimentation rate by Westergren method
308
2463
1.58
6.26
4.0
4.2
mm/h
19.0
16.9
1.04
272
2220
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
358
2967
1.60
6.22
6.3
7.0
mmol/mol
42.3
42.0
0.17
319
2653
(3004119) Hemoglobin [Mass/volume] in Venous blood
59
296
2.11
6.22
2.0
3.0
g/l
124.2
122.9
0.16
59
288
(3006504) Eosinophils/100 leukocytes in Blood
209
1531
1.59
6.20
6.1
5.3
%
2.8
2.7
0.13
195
1404
(3004789) Transferrin [Mass/volume] in Serum or Plasma
111
690
1.76
6.19
2.2
2.5
g/l
2.2
2.3
1.09
96
630
(3014111) Lactate [Moles/volume] in Serum or Plasma
70
376
1.99
6.15
3.4
5.9
mmol/l
1.5
1.5
0.10
65
353
(3002385) Erythrocyte distribution width [Ratio]
313
2519
1.57
6.14
36.3
24.1
%
14.6
14.2
4.07
306
2451
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
111
693
1.76
6.09
3.9
3.3
e6/l
1.4
2.2
0.92
51
408
(3019069) Monocytes/100 leukocytes in Blood
209
1538
1.58
6.04
7.1
5.6
%
9.0
9.1
0.17
194
1416
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
114
721
1.73
5.97
3.9
3.1
e6/l
1.3
1.3
0.06
55
432
(3018010) Neutrophils/100 leukocytes in Blood
207
1532
1.57
5.78
6.2
5.5
%
61.6
60.0
0.91
192
1412
(3013115) Eosinophils [#/volume] in Blood
221
1661
1.56
5.76
5.8
5.2
e9/l
0.2
0.2
0.15
180
1431
(3013650) Neutrophils [#/volume] in Blood by Automated count
246
1897
1.54
5.69
7.3
8.1
e9/l
4.7
4.5
0.72
198
1636
(3024354) Oxygen [Partial pressure] in Venous blood
69
379
1.94
5.68
2.1
2.9
kpa
3.9
4.3
1.26
62
358
(3006315) Basophils [#/volume] in Blood
214
1609
1.54
5.51
5.6
5.1
e9/l
0.0
0.0
0.03
178
1356
(3007853) Bacteria identified in Skin by Aerobe culture
76
436
1.86
5.49
1.6
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
387
3311
1.58
5.48
11.5
11.0
u/l
22.1
23.3
0.54
368
3152
(3019198) Lymphocytes [#/volume] in Blood
217
1639
1.54
5.46
5.9
5.3
e9/l
1.8
1.8
0.12
180
1417
(3022948) Iron [Moles/volume] in Serum or Plasma
115
747
1.68
5.43
2.3
2.5
umol/l
10.8
11.4
0.39
103
682
(3001604) Monocytes [#/volume] in Blood
212
1600
1.53
5.32
5.6
5.1
e9/l
0.7
0.6
1.87
176
1342
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
216
1637
1.53
5.32
4.8
4.4
—
—
—
0
0
(44790049)
15
39
3.93
5.29
1.2
1.5
—
—
—
0
0
(44806118)
15
39
3.93
5.29
1.2
1.5
—
—
—
0
0
(44790047)
15
39
3.93
5.29
1.2
1.5
—
—
—
0
0
(44790048)
15
39
3.93
5.29
1.2
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
90
563
1.72
4.86
3.9
4.8
mmol/l
1.0
1.0
0.56
82
522
(3012095) Magnesium [Moles/volume] in Serum or Plasma
99
636
1.68
4.85
2.5
2.7
mmol/l
0.8
0.8
1.38
90
593
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
55
298
1.94
4.72
2.7
3.9
ng/l
103.7
105.7
0.06
44
255
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
58
322
1.90
4.64
1.8
2.4
u/l
30.1
32.6
0.37
46
276
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
40
196
2.12
4.51
2.0
1.8
ug/l
4.7
2.9
0.30
27
172
(1761868) Lipid panel - Serum or Plasma
42
764
0.51
4.30
2.7
3.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
113
775
1.58
4.23
4.3
4.4
—
—
—
0
0
(3044889) 12 lead EKG panel
286
2387
1.42
3.91
4.8
4.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
27
121
2.30
3.80
1.8
2.8
pmol/l
4.2
4.1
0.21
21
105
(36660697) Celiac disease serology panel - Serum
34
168
2.09
3.78
1.1
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
194
1530
1.42
3.58
4.3
3.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
69
437
1.66
3.56
2.0
2.8
ug/l
5.3
6.3
0.20
47
380
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
352
3074
1.41
3.56
4.5
5.3
mmol/l
6.3
6.2
0.28
302
2679
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
41
223
1.91
3.52
1.8
2.4
%
0.7
0.6
0.10
41
217
(3027945) Reticulocytes/100 erythrocytes in Blood
85
571
1.58
3.46
3.1
2.3
%
1.7
1.8
0.13
68
503
(3006653) Thiamine [Moles/volume] in Blood
7
10
7.07
3.37
1.0
1.1
nmol/l
123.3
133.2
—
7
10
(3037756) Immunofixation for Serum or Plasma
24
109
2.26
3.30
1.2
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
7
8.65
3.27
1.7
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
64
408
1.64
3.23
4.0
5.9
mmol/l
12.3
13.4
0.44
59
382
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
62
394
1.65
3.17
2.3
2.6
umol/l
11.6
10.5
0.07
49
343
(3042936) Bacteria identified in Isolate by Culture
84
577
1.54
3.10
1.8
2.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
5
10.08
2.98
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
53
329
1.68
2.97
1.3
2.0
g/l
0.2
0.2
1.37
45
299
(3023520) Reticulocytes [#/volume] in Blood
63
410
1.61
2.94
2.5
2.3
e9/l
62.8
66.4
0.36
44
327
(3027273) Bicarbonate [Moles/volume] in Venous blood
43
254
1.75
2.88
2.2
3.1
mmol/l
26.7
24.9
2.54
43
245
(3051611) Lipemic interference index of Serum or Plasma
13
47
2.81
2.83
4.5
4.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
97
2.21
2.80
1.3
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
91
2.24
2.77
1.2
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
12
42
2.90
2.76
1.3
1.3
mosm/kgh2o
275.4
271.2
—
7
27
(3019230) Fractional oxyhemoglobin in Venous blood
17
72
2.40
2.75
1.2
2.1
%
52.3
59.5
0.63
17
72
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
183
1.86
2.71
1.7
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
119
2.06
2.70
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
119
2.06
2.70
1.6
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
67
2.43
2.65
1.2
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
61
2.50
2.64
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
186
1.82
2.59
2.8
2.1
u/ml
0.3
0.3
0.10
15
111
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
164
1.88
2.59
1.6
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
30
164
1.88
2.59
3.7
3.3
nmol/l
0.8
0.9
0.85
22
131
(3017143) Hepatitis C virus Ab [Presence] in Serum
34
194
1.80
2.57
1.2
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
145
1145
1.36
2.54
4.7
3.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
203
1687
1.32
2.52
4.8
4.7
ng/l
37.8
50.2
1.18
168
1360
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
115
876
1.40
2.50
2.0
2.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
174
1.83
2.47
2.5
2.2
g/l
10.1
10.3
0.08
18
145
(3026493) Urate [Moles/volume] in Serum or Plasma
125
969
1.38
2.45
3.0
2.9
umol/l
386.4
8415.6
4.16
103
794
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
176
1.81
2.39
2.4
2.2
g/l
3.1
3.3
0.33
19
134
(3022217) INR in Platelet poor plasma by Coagulation assay
97
727
1.41
2.31
31.8
32.8
inr
1.5
1.5
—
5
87
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
191
1590
1.31
2.31
4.5
6.1
ug/l
15.2
4.7
0.39
154
1384
(3035350) Ketones [Presence] in Urine by Test strip
203
1704
1.30
2.31
4.7
4.5
estimate
0.0
0.0
0.00
28
347
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
127
998
1.36
2.28
3.2
2.6
u/l
29.7
36.9
2.33
113
957
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
341
3068
1.30
2.26
4.8
5.4
mmol/l
2.2
2.4
3.73
309
2694
(3052851) Hemolysis interference index of Serum or Plasma
24
128
1.92
2.25
6.3
4.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
164
1346
1.31
2.18
4.5
3.7
e6/l
55.0
120.1
0.64
118
1084
(3019225) pH of Specimen
52
349
1.54
2.17
5.1
4.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
19
3.72
2.15
2.0
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
178
1480
1.30
2.14
5.3
4.2
e6/l
333.3
176.5
0.25
121
1143
(46235355) HIV 1 and 2 tests - Meaningful Use set
38
237
1.65
2.14
1.3
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
21
109
1.96
2.13
1.8
3.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
245
0.44
2.05
1.3
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
90
2.03
2.02
1.2
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
90
2.03
2.02
1.3
1.4
ug/g
292.4
268.9
0.23
12
51
(3017704) Immunofixation for Urine
8
26
3.11
2.02
1.0
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
187
1.70
1.98
2.5
2.1
g/l
3.9
3.7
0.36
19
129
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
191
1617
1.28
1.98
2.8
3.4
ng/l
2197.3
2442.1
0.37
160
1424
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
188
1.69
1.95
2.5
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
188
1.69
1.95
2.5
2.1
g/l
7.7
7.6
0.02
19
133
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
16
3.78
1.94
1.0
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
27
159
1.73
1.89
2.7
2.5
g/l
1.9
0.9
0.39
20
132
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
325
2946
1.26
1.84
3.9
4.7
mmol/l
4.0
4.2
4.20
284
2615
(3021601) Nitrite [Presence] in Urine by Test strip
198
1698
1.26
1.82
6.9
6.2
estimate
0.0
0.0
0.00
28
337
(3026389) Candida sp identified in Specimen by Organism specific culture
10
41
2.47
1.76
1.5
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
107
1319
0.77
1.71
2.1
2.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
48
0.00
1.70
0.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
47
327
1.48
1.69
2.3
2.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
152
1275
1.27
1.66
4.3
5.0
%
22.2
21.8
0.12
77
692
(3030467) Casts [#/volume] in Urine by Automated count
146
1221
1.27
1.64
4.8
3.6
e6/l
0.3
0.5
0.76
106
970
(3009261) Glucose [Presence] in Urine by Test strip
198
1718
1.24
1.61
5.0
4.6
estimate
0.0
0.0
0.00
28
334
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
32
207
1.58
1.61
1.3
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
143
1197
1.26
1.59
2.4
2.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
26
2.71
1.58
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
176
1.62
1.58
1.4
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
17
92
1.88
1.57
1.1
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
57
2.13
1.56
1.8
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
64
2.06
1.55
1.8
2.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
23
140
1.67
1.47
2.1
2.2
g/l
0.0
0.0
0.48
18
124
(3017181) Myelocytes/100 leukocytes in Blood
17
290
0.57
1.47
4.0
3.8
%
1.7
0.9
—
6
101
(3051651) Icteric interference index of Serum or Plasma
7
28
2.52
1.45
4.6
4.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
39
2.33
1.43
1.3
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
24
149
1.64
1.43
2.2
2.1
g/l
36.6
36.1
0.17
18
123
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
9
40
2.27
1.40
1.7
1.3
mmol/l
4.5
3.9
—
9
35
(3002256) Pathology report gross observation
34
484
0.68
1.36
1.3
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
38
0.00
1.35
0.0
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
61
1.99
1.33
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
18
106
1.72
1.31
1.3
1.9
s
20.3
21.0
0.40
18
101
(4035726)
20
314
0.62
1.27
1.3
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
44
2.06
1.27
1.1
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
315
2909
1.20
1.27
3.9
4.7
mmol/l
1.3
1.4
2.32
272
2548
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
25
2.42
1.24
1.0
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
47
349
1.38
1.24
1.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
93
763
1.26
1.23
5.7
5.1
kg/l
1.0
1.0
0.85
12
128
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
56
1.98
1.23
1.1
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
68
536
1.31
1.22
3.8
3.5
u/l
232.8
244.7
0.69
62
504
(3044927) Protein electrophoresis panel - Urine
10
50
2.02
1.17
1.2
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
35
252
1.42
1.11
4.3
7.4
mmol/l
25.2
24.6
0.38
27
229
(3020891) Body temperature
26
177
1.49
1.10
5.1
4.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
89
1.70
1.08
1.3
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
113
965
1.22
1.05
3.4
3.2
mosm/kgh2o
550.1
545.1
0.09
93
821
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
22
2.28
1.03
1.0
1.2
—
6.8
—
0
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
303
2820
1.17
1.02
3.5
4.2
mmol/l
1.2
1.2
0.00
258
2448
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
176
0.56
1.01
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
35
2.01
1.00
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
35
2.01
1.00
1.4
1.3
%
8.5
10.2
—
7
35
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
31
0.00
0.96
0.0
1.2
—
—
—
0
0
(4281824)
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
49
619
0.77
0.96
4.6
4.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
51
1.78
0.95
1.2
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
27
2.24
0.93
1.5
1.1
nmol/l
1.8
1.7
—
6
22
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
34
254
1.36
0.91
2.6
2.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
103
1.57
0.88
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
95
1.60
0.88
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
99
850
1.20
0.88
5.5
6.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
30
2.01
0.87
1.5
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
43
336
1.30
0.86
3.6
4.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
96
1.58
0.85
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
97
1.56
0.82
1.2
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
33
1.83
0.79
1.8
1.4
—
68.0
—
0
5
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
48
1.68
0.79
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
174
0.62
0.78
1.4
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
444
1.24
0.74
4.4
4.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
132
0.60
0.74
4.6
2.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
49
399
1.25
0.73
2.3
2.4
g/l
64.6
65.7
0.48
40
359
(3044290) Cell count panel - Cerebral spinal fluid
7
38
1.85
0.73
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
106
0.56
0.73
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
40
1.76
0.71
1.3
1.5
—
—
—
0
0
(4034850)
15
101
1.50
0.71
6.8
12.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
168
0.65
0.68
1.0
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
34
269
1.28
0.65
2.7
3.8
mmol/l
2.8
1.9
0.77
26
204
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
62
1.62
0.65
1.1
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
60
508
1.20
0.64
1.3
1.2
u/ml
0.8
1.4
—
6
124
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
21
155
1.37
0.64
3.2
4.4
mmol/l
26.3
24.8
1.07
16
146
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
71
1.56
0.62
1.4
1.2
—
—
—
0
0
(3013512) EKG study
107
1193
0.87
0.61
4.4
4.9
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
21
0.00
0.60
0.0
1.3
—
46.6
—
0
9
(3000492) Spirometry study
16
220
0.72
0.60
1.7
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
36
1.67
0.57
1.0
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
18
133
1.37
0.55
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
26
326
0.79
0.53
6.4
4.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
63
1.44
0.52
1.2
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
126
1159
1.11
0.47
2.7
3.2
mg/l
1925.6
331.2
1.08
89
778
(3009343) pH of Capillary blood
34
283
1.21
0.46
2.7
3.8
ph
7.4
7.4
—
5
34
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
19
241
0.78
0.44
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
262
0.79
0.43
7.5
3.7
—
—
—
0
0
(4015189)
0
15
0.00
0.41
0.0
3.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
16
0.00
0.41
0.0
1.6
—
722.3
—
0
7
(4062490)
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
20
249
0.80
0.41
6.5
4.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
17
0.00
0.40
0.0
1.5
—
24.1
—
0
17
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
81
735
1.12
0.39
1.6
1.6
mg/l
1.8
1.6
0.35
66
595
(3017732) Neutrophils [#/volume] in Blood
23
188
1.23
0.38
5.4
2.8
e9/l
5.1
4.2
0.69
16
131
(3051387) C reactive protein [Mass/volume] in Capillary blood
8
113
0.70
0.37
4.3
4.0
mg/l
33.4
31.7
—
8
77
(3009508) Creatinine [Moles/volume] in Urine
123
1147
1.09
0.36
2.6
3.2
mmol/l
6.7
6.5
0.16
104
940
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
42
1.43
0.35
1.0
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
108
1.30
0.35
3.5
4.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
46
1.31
0.33
2.8
3.3
u/ml
26.0
41.6
—
6
46
(40768793) Breast Pathology biopsy report
6
46
1.31
0.33
1.7
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
29
248
1.18
0.32
2.1
1.9
ug/g
177.3
184.4
0.04
24
190
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
75
1.34
0.30
1.3
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
63
1.27
0.28
1.9
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
9
119
0.75
0.27
2.3
2.6
kpa
7.5
8.0
—
9
108
(40768806) Pleura Pathology biopsy report
9
75
1.20
0.25
1.0
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
85
907
0.93
0.24
2.9
3.4
ug/l
0.9
0.9
0.15
59
650
(4146454)
5
38
1.32
0.23
2.0
2.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
39
1.28
0.23
3.0
2.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
41
1.22
0.22
1.6
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
367
0.89
0.22
1.2
1.3
u/ml
1.0
17.3
—
5
136
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.6
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
42
1.19
0.21
1.6
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
41.6
—
0
10
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
0.7
—
0
10
(3021901) Oxygen saturation in Capillary blood
8
102
0.78
0.21
2.5
2.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
43
1.16
0.21
1.6
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
17
198
0.85
0.21
1.6
2.0
nmol/l
8.3
10.4
—
10
163
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
18.9
—
0
8
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
1.1
—
0
7
(3033799) Differential panel - Peritoneal fluid
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(4211845)
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.3
—
173.8
—
0
13
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.1
—
1.5
—
0
9
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
14
0.00
0.20
0.0
1.1
—
353.1
—
0
8
(3022313) Gas panel - Capillary blood
23
203
1.14
0.19
2.7
3.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
89
938
0.94
0.19
5.7
4.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
16
137
1.17
0.19
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
175
1.15
0.18
3.0
3.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
53
1.13
0.18
3.2
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
42
387
1.09
0.18
1.2
1.3
iu/ml
90.9
44.3
0.52
15
131
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
121
0.82
0.18
1.4
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
61
1.15
0.17
4.4
2.8
e9/l
9.2
5.0
—
7
61
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
82
1.22
0.17
1.4
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
50
466
1.08
0.17
1.4
1.4
g/l
2.8
2.7
0.20
22
266
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
137
1321
1.05
0.17
6.0
5.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
68
0.73
0.17
7.6
3.8
%
3.2
0.8
—
5
52
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
77
0.78
0.15
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
80
0.75
0.15
1.0
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
96
0.83
0.14
1.6
2.2
mg/l
2.3
2.1
—
8
81
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
128
0.86
0.13
2.0
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
44
467
0.94
0.12
2.6
3.8
ug/l
5.3
34.0
1.05
38
403
(3049717) Cytology report of Urine Cyto stain
26
239
1.09
0.12
3.2
3.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
127
1233
1.04
0.12
3.2
4.0
mg/mmol
16.2
10.9
0.51
87
813
(3022145) Colonoscopy Study observation
35
327
1.08
0.12
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
168
0.89
0.12
5.9
5.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
143
1463
0.97
0.10
10.1
11.2
e9/l
0.0
0.0
0.22
106
1182
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
58
1.03
0.08
4.5
3.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
(4094501)
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
64
1.09
0.08
6.7
3.3
%
72.4
64.9
—
7
64
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
85
1.06
0.07
1.9
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
446
1.03
0.05
12.5
9.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
13
139
0.93
0.03
2.5
3.1
mmol/l
25.3
25.1
0.07
13
117
(3037121) Protein [Mass/volume] in Urine
15
141
1.07
0.03
1.9
2.7
g/l
0.8
0.3
—
6
53
(40768797) Stomach Pathology biopsy report
44
429
1.03
0.03
1.1
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
102
1007
1.02
0.03
3.5
2.9
e6/l
4.2
4.4
0.10
93
889
(3029937) Albumin [Presence] in Urine by Test strip
94
951
0.99
0.02
6.2
4.8
estimate
0.0
0.0
0.00
25
321
(3003694) ABO and Rh group [Type] in Blood
71
718
0.99
0.01
1.1
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
42
427
0.98
0.01
3.8
4.9
%
36.4
33.3
0.84
23
267
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
275
1.02
0.00
3.9
3.5
ml/min/173m2
59.3
53.5
0.41
12
138
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
103
0.97
0.00
1.2
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
117
1.03
0.00
1.1
1.4
—
30.4
—
0
6
(4010399)
22
222
0.99
0.00
1.2
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
111
0.99
0.00
1.4
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
291
2912
1.00
0.00
26.7
19.5
ml/min/173m2
64.3
65.6
0.48
226
2460
(3045788) Cell count panel - Pleural fluid
6
62
0.97
0.00
1.3
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.4
—
97.1
—
0
8
(21494434) Karyotype in Bone marrow
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.7
—
76.2
—
0
6
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
85
0.94
0.00
1.1
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
1.0
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
99
0.91
0.00
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
6.0
—
0
6
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.2
1.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
5
53
0.94
0.00
1.0
1.2
—
106.2
—
0
8
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
3.8
—
63.2
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.1
—
0
6
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
7
79
0.88
0.00
1.3
1.2
—
2.6
—
0
7
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
56
0.89
0.00
1.4
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
111.3
—
0
6
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
8.8
—
0
5
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
63
0.95
0.00
1.0
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
9
91
0.99
0.00
1.2
1.5
g/l
27.0
28.8
—
9
82
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.2
—
76.4
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint VD_MX and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_MX | 2.524 [2.11, 3.03] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.455 |
During the follow-up period (1.1.1998 — 31.12.2019), 1669 out of 2264 females with VD_MX died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_MX | 3.271 [2.52, 4.24] | < 0.001 |
| Birth year | 0.982 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1385 out of 1903 males with VD_MX died.
Mortality risk
Mortality risk for people of age
years, who have VD_MX.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.245% | 0.504% |
| 5 | 1.626% | 3.072% |
| 10 | 3.872% | 7.683% |
| 15 | 7.553% | 14.956% |
| 20 | 13.309% | 24.423% |
Relationships between endpoints
↥Index endpoint: VD_MX – Vascular dementia (mixed)
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data